2'-hydroxyflavone has been researched along with 2'-hydroxyflavanone in 1 studies
Studies (2'-hydroxyflavone) | Trials (2'-hydroxyflavone) | Recent Studies (post-2010) (2'-hydroxyflavone) | Studies (2'-hydroxyflavanone) | Trials (2'-hydroxyflavanone) | Recent Studies (post-2010) (2'-hydroxyflavanone) |
---|---|---|---|---|---|
10 | 0 | 4 | 41 | 0 | 32 |
Protein | Taxonomy | 2'-hydroxyflavone (IC50) | 2'-hydroxyflavanone (IC50) |
---|---|---|---|
Androgen receptor | Homo sapiens (human) | 3.7 | |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | Homo sapiens (human) | 10 | |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.2333 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, M; Izumi, K; Mizokami, A; Nakagawa-Goto, K; Saito, Y; Tsurimoto, H | 1 |
1 other study(ies) available for 2'-hydroxyflavone and 2'-hydroxyflavanone
Article | Year |
---|---|
5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonoids; Humans; Male; Mice; Mice, SCID; Molecular Structure; Neoplasms, Experimental; Prostatic Neoplasms; Receptors, Androgen; Structure-Activity Relationship | 2018 |